Also, it negatively regulated UCEC tumor development stage 1, stage 2 and stage 3, and differentiation grade 3 (Figure 2B) and significantly negatively regulated the progression of LUAD tumors, in which tumor onset was associated with TP53 mutation (p < 0.05) (Figure 2C). The gene discussed is TP53; the disease is neoplasm.